Remote Neuromodulation

Deployed transcranial electrical stimulation, without compromise.

Soterix Medical REMOTE Neuromodulation (ARTG Entry: 284637) is the only system with device, accessories, and software designed for deployed use. Safe transcranial Electrical Stimulation requires advanced systems designed for consistency and control. REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.


mini-CT device  

Fail-safe and intelligent hand-held stimulators designed specifically for deployed use. Deliver only the right dose at the right time, with onboard compliance recording and ElectraRx compatibility. 

Learn more...

snapstrap (2).png

SNAP Headgear accessories  

The only head-gear that is simple to self-apply and guarantees accurate electrode placement. The only pre-saturated snap electrodes for tES in deployed environment.

Learn more...


ElectraRx software  

ElectraRx integrates complete screening and assessments, tDCS dose management, and online digital therapeutics all in one place that can be accessed from anywhere.
Learn more...

Regulatory Approval 

Our Clinical TES systems are approved by the Australian Government's Therapeutic Goods Administration (TGA)  ARTG Entry: 284637

Clinical Systems

Soterix Medical is committed to provide patients and physicians the most advanced, user-friendly, and effective neuromodulation treatments. Our clinical tDCS platforms are the only system to incorporate the latest, most robust technology. Unique electrode and head-gear snap-in technology make consistent and comfortable stimulation “a snap” for patient and care-givers.

Explore How The Depression tDCS-LTE™ System Works...

Explore How The PainX™ tDCS System Works...

What tDCS?

Transcranial Direct Current Stimulation (tDCS) is a non-invasive procedure in which a device sends a small Direct Current (DC) across the scalp to modulate brain function. 

tDCS mechanisms are considered to result from the ability of very weak DC currents to safely induce reversible changes in cortical plasticity. The induction of lasting changes in cortical excitability can, under some conditions, reversibly modify behavior and interact with normal learning. Such findings have driven a large number of studies examining whether tDCS might induce functionally significant changes in patients with a large variety of neurological and psychiatric disorders.

Evidence based:


Depression LTE

Pain X

Soterix Medical REMOTE Neuromodulation systems are uniquely validated

Soterix Medical hardware and accessories for remote use is the only equipment designed and validated for the purpose. Other systems designed for use by professional and medical and research centers cannot be rigged for home use.


Soterix Medical REMOTE is supported by over a dozen clinical trials including the demonstration of tolerability, reproducibility, and compliance.

Clinical Trials

The Soterix 1x1 CT is the most advanced and customizable system for true double-blinded trials.


Models: CT-tDCS and CT-tES

Double Blind: Customizable stimulation for true clinician and patient blinded studies for unbiased results

SMARTscan PLUS: Continuous indication of quality without compromising blind.

Integration: Combine with a 4X1 device to obtain 4x1 HD Stimulation while leveraging all the unique features of the 1x1 platform. 


HD Software Compatible: Compatible with Soterix Medical’s revolutionary neurotargeting softwares HD-Targets and HD-Explore


Other Features:  Customization options available